Literature DB >> 2165895

Skeletal muscle and whole-body protein turnover in cirrhosis.

W L Morrison1, I A Bouchier, J N Gibson, M J Rennie.   

Abstract

1. We investigated arteriovenous exchanges of tyrosine and 3-methylhistidine across leg tissue in the postabsorptive state as specific indices of net protein balance and myofibrillar protein breakdown, respectively, in eight patients with cirrhosis and in 11 healthy control subjects. Whole-body protein turnover was also measured using L-[1-13C]leucine. 2. Leg efflux of tyrosine was 45% greater in cirrhotic patients than in normal control subjects [-6.5(1.4 to -19.1) vs -4.2(-2.2 to -7.7) mumol min-1 100 mg-1 of leg, median (range), P less than 0.025]. 3-Methylhistidine efflux was not significantly altered. 3. In cirrhosis, whole-body leucine flux was normal but whole-body leucine oxidation was elevated so that whole-body protein synthesis was depressed by 17%. 4. The results indicate the predominant mechanism of muscle wasting in cirrhosis to be a fall in muscle protein synthesis, which is accompanied by an overall fall in whole-body protein turnover.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165895     DOI: 10.1042/cs0780613

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  22 in total

1.  Cardiac cachexia.

Authors:  W L Morrison; R H Edwards
Journal:  BMJ       Date:  1991-02-09

2.  Metabolic effects of liver transplantation in cirrhotic patients.

Authors:  L Luzi; G Perseghin; E Regalia; L P Sereni; A Battezzati; D Baratti; E Bianchi; I Terruzzi; H Hilden; L C Groop; A Pulvirenti; M R Taskinen; L Gennari; V Mazzaferro
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  Alcohol and muscle disease.

Authors:  V R Preedy; T J Peters
Journal:  J R Soc Med       Date:  1994-04       Impact factor: 5.344

Review 4.  Metabolism of energy-yielding substrates in patients with liver cirrhosis.

Authors:  M J Müller; K H Böker; O Selberg
Journal:  Clin Investig       Date:  1994-08

5.  Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis.

Authors:  Cynthia Tsien; Gangarao Davuluri; Dharmvir Singh; Allawy Allawy; Gabriella A M Ten Have; Samjhana Thapaliya; John M Schulze; David Barnes; Arthur J McCullough; Marielle P K J Engelen; Nicolaas E P Deutz; Srinivasan Dasarathy
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

Review 6.  Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy.

Authors:  G Kircheis; M Wettstein; S vom Dahl; D Häussinger
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

7.  Methionine metabolism in human pregnancy.

Authors:  Jaividhya Dasarathy; Lourdes L Gruca; Carole Bennett; Prabhu S Parimi; Clarita Duenas; Susan Marczewski; Julie L Fierro; Satish C Kalhan
Journal:  Am J Clin Nutr       Date:  2009-11-25       Impact factor: 7.045

Review 8.  Posttransplant sarcopenia: an underrecognized early consequence of liver transplantation.

Authors:  Srinivasan Dasarathy
Journal:  Dig Dis Sci       Date:  2013-08-04       Impact factor: 3.199

9.  Treatment to improve nutrition and functional capacity evaluation in liver transplant candidates.

Authors:  Srinivasan Dasarathy
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06

Review 10.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.